Showing results (191-200 of 230) with videos related to
Sort By:
Pageof 23
Blood|February 1, 1989
Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older childrenS M Hanash, R Kuick, J Strahler, et al.Cancer Research|February 1, 1992
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent scheduleP C Adamson, F M Balis, J Miser, et al.Cancer Research|September 15, 1989
Phase I trial and pharmacokinetic evaluation of fazarabine in childrenR L Heideman, A Gillespie, H Ford, et al.The Journal of Clinical Investigation|February 1, 1992
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemiaC A Felix, M M Nau, T Takahashi, et al.Cancer Research|September 1, 1981
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemiaD G Poplack, S E Sallan, G Rivera, et al.Cancer|March 1, 1978
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapseF R Appelbaum, A B Deisseroth, R G Graw, et al.Leukemia & Lymphoma|February 26, 1998
Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer GroupF M Uckun, H Sather, P Gaynon, et al.Blood|February 15, 1995
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemiaF M Uckun, H Sather, G Reaman, et al.Cancer|January 15, 1992
Choroid plexus carcinoma of childhoodR J Packer, G Perilongo, D Johnson, et al.Cancer Research|August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day scheduleP C Adamson, F M Balis, J Miser, et al.Pageof 23